ACQUISITION OF NON-CATALOGED MEDICINES GROUP P (ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS) FIRST QUARTER - 2025 PROGRAMMING.- PHARMACY AND THERAPEUTICS COMMITTEE MINUTES 002 – 2025

This tender concerns the acquisition of non-cataloged medicines specifically within Group P, which includes antiparasitic products, insecticides, and repellents. The procurement is scheduled for the first quarter of 2025, as part of the annual programming. This process is based on the minutes of the Pharmacy and Therapeutics Committee, specifically Act 002 for the year 2025. The contracting entity responsible for this tender is the CENTRO CLINICO QUIRURGICO AMBULATORIO HOSPITAL DEL DIA "MARIA ROSA PARRA ARREAGA" (CCQA-HD SAMBORONDON). The procurement method specified is Electronic Reverse Auction (Subasta Inversa Electrónica), a modality designed to achieve competitive pricing. A key item required under this tender is Metronidazole, presented in solid oral form, with a dosage of 500 mg, packaged in boxes of blister packs/strips. The specified quantity for this item is 39,300 units, with an estimated value of USD 12,756.70. This procurement aims to ensure the availability of essential pharmaceutical products for the specified healthcare facility during the first part of 2025, focusing on treatments for parasitic infections and pest control. Interested suppliers are expected to meet the technical specifications and adhere to the procedures of the electronic reverse auction.

This is a supplies contract in the governance and public administration sector. Located in Ecuador, Latin America, this opportunity is open to firms and consortiums, with an estimated budget of USD 12,757.

Published through SERCOP Ecuador, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the governance and public administration sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.